Cargando…

Pharmaceutical Industry in Syria

The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the governme...

Descripción completa

Detalles Bibliográficos
Autor principal: Kutaini, D
Formato: Texto
Lenguaje:English
Publicado: Carol Davila University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018990/
https://www.ncbi.nlm.nih.gov/pubmed/20945828
_version_ 1782196138009427968
author Kutaini, D
author_facet Kutaini, D
author_sort Kutaini, D
collection PubMed
description The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author.
format Text
id pubmed-3018990
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-30189902011-03-03 Pharmaceutical Industry in Syria Kutaini, D J Med Life Student Message Board The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author. Carol Davila University Press 2010-08-15 2010-08-25 /pmc/articles/PMC3018990/ /pubmed/20945828 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Student Message Board
Kutaini, D
Pharmaceutical Industry in Syria
title Pharmaceutical Industry in Syria
title_full Pharmaceutical Industry in Syria
title_fullStr Pharmaceutical Industry in Syria
title_full_unstemmed Pharmaceutical Industry in Syria
title_short Pharmaceutical Industry in Syria
title_sort pharmaceutical industry in syria
topic Student Message Board
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018990/
https://www.ncbi.nlm.nih.gov/pubmed/20945828
work_keys_str_mv AT kutainid pharmaceuticalindustryinsyria